Wave Life Sciences Ltd. Ordinary Shares
Here’s whether Wave Life Sciences Ltd. Ordinary Shares (WVE) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-4.21% over 10 days); weak 1-year return of -30.8%; 3-month momentum negative (-19.1%). Currently 73.3% off its 52-week high. Score: -6/7.
WVE is trading below its 200-day MA ($9.65) — a key warning sign the longer-term trend is under pressure. An RSI of 34.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -30.8% compares to +16.5% for SPY (trailed the market by 47.2%). The current 73.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.